In Re Ralph R. Grams and Dennis C. Lezotte

888 F.2d 835, 12 U.S.P.Q. 2d (BNA) 1824, 1989 U.S. App. LEXIS 16528, 1989 WL 130053
CourtCourt of Appeals for the Federal Circuit
DecidedNovember 3, 1989
Docket89-1321
StatusPublished
Cited by39 cases

This text of 888 F.2d 835 (In Re Ralph R. Grams and Dennis C. Lezotte) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In Re Ralph R. Grams and Dennis C. Lezotte, 888 F.2d 835, 12 U.S.P.Q. 2d (BNA) 1824, 1989 U.S. App. LEXIS 16528, 1989 WL 130053 (Fed. Cir. 1989).

Opinion

ARCHER, Circuit Judge.

Applicants Ralph A. Grams and Dennis C. Lezotte (Grams) appeal from the decision of the Board of Patent Appeals and Interferences (Board), United States Patent and Trademark Office, Appeal No. 88-1391 (December 28, 1988), affirming the examiner’s rejection of claims 1 and 3-16, which constitute all the claims remaining in Application S.N. 625,247, filed June 27, 1984. The claims were rejected under 35 U.S.C. § 101 as being directed to nonstatutory subject matter because they in essence claim either a mathematical algorithm or a method of doing business. We affirm.

BACKGROUND

The invention provides a method of testing a complex system to determine whether the system condition is normal or abnormal and, if it is abnormal, to determine the cause of the abnormality. As disclosed in the specification, the invention is applicable to any complex system, whether it be electrical, mechanical, chemical, biological, or combinations thereof. The system comprises a plurality of constituent subsystems or parts, some characteristic of which is represented by a set of correlated parameters susceptible of measurement and representative of the overall system. The disclosed invention involves considering the entire set of parameters, diagnosing the existence of an abnormality, and identifying which particular parameters of the set are responsible for the abnormality.

The claims limit the disclosed invention to the diagnosis of an individual. Claim 1, on which the other claims depend, reads:

1. A method of diagnosing an abnormal condition in an individual, the individual being characterized by a plurality of correlated parameters of a set of such parameters that is representative of the individual’s condition, the parameters comprising data resulting from a plurality of clinical laboratory tests which measure the levels of chemical and biological constituents of the individaul [sic] and each parameter having a reference range of values, the method comprising [a] performing said plurality of clinical laboratory tests on the individual to measure the values of the set of parameters; [b] producing from the set of measured parameter values and the reference ranges of values a first quantity representative of the condition of the individual; [c] comparing the first quantity to a first predetermined value to determine whether the individual’s condition is abnormal; [d] upon determining from said comparing that the individual’s condition is abnormal, successively testing a plurality of different combinations of the constituents of the individual by eliminating parameters from the set to form subsets corresponding to said combinations, pro- *837 dueing for each subset a second quantity, and comparing said second quantity with a second predetermined value to detect a non-significant deviation from a normal condition; and [e] identifying as a result of said testing a complementary subset of parameters corresponding to a combination of constituents responsible for the abnormal condition, said complementary subset comprising the parameters eliminated from the set so as to produce a subset having said non-significant deviation from a normal condition.

(Emphasis and bracketed letters added.) Thus, step [a] requires the performance of clinical laboratory tests on an individual to obtain data for the parameters {e.g., sodium content). The remaining steps, [b]-[e], analyze that data to ascertain the existence and identity of an abnormality, and possible causes thereof. In that regard, steps [b]-[e] are in essence a mathematical algorithm, in that they represent “[a] procedure for solving a given type of mathematical problem.” Gottschalk v. Benson, 409 U.S. 63, 65, 93 S.Ct. 253, 254, 34 L.Ed.2d 273 (1972). 1

Applicants do not dispute that claim 1 includes a mathematical algorithm. However, they contend that the mere recital of an algorithm does not automatically render a claim nonstatutory. They are correct in that regard, but the inclusion of a mathematical algorithm in a claim can render it nonstatutory if the claim in essence covers only the algorithm. The Board held that was the case here.

ISSUE

Whether the algorithm-containing claims at issue are drawn to statutory subject matter.

OPINION

Section 101 of Title 35 states:

Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title.

(Emphasis added.) Intuitively, one might conclude that the statute’s “any ... process” would include the diagnostic method claimed by applicants. Indeed, even without physical step [a] present in the claims, application of the algorithm in steps [b]-[e] seems to be a type of “process”. The Supreme Court recognized as much in Parker v. Flook, 437 U.S. 584, 588-89, 98 S.Ct. 2522, 2524-25, 57 L.Ed.2d 451 (1978).

Flook makes clear, however, as did its forerunner, Gottschalk v. Benson, 409 U.S. 63, 93 S.Ct. 253, 34 L.Ed.2d 273 (1972), that even though the application of an algorithm to data is a “process” in the literal sense, it is not one that is contemplated by section 101, i.e., it is “nonstatutory subject matter.” Thus, mathematical algorithms join the list of non-patentable subject matter not within the scope of section 101, including methods of doing business, naturally occurring phenomenon, and laws of nature. In re Sarkar, 588 F.2d 1330, 1335-36, 200 USPQ 132, 136-37 (CCPA 1978); In re Chatfield, 545 F.2d 152, 157, 191 USPQ 730, 735 (CCPA 1976).

Construing section 101 as excluding mathematical algorithms seems somewhat at odds with the liberal view of that section expressed in a more recent Supreme Court opinion, Diamond v. Chakrabarty, 447 U.S. 303, 308-09, 314-16, 100 S.Ct. 2204, 2207-08, 2210-11, 65 L.Ed.2d 144 (1980). There, the Court decided that a living man-made micro-organism fell within the terms “manufacture” or “composition of matter” in section 101. In choosing such “expansive terms”, stated the Court, “modified by the comprehensive ‘any,’ Congress plainly contemplated that the patent laws would be given wide scope.” Id. The Court went so far as to note that Congress intended statutory subject matter to include “ ‘anything under the sun that is made by man.’ ” Chakrabarty, 447 U.S. at 309, 100 S.Ct. at *838

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Citrix Sys., Inc. v. Avi Networks, Inc.
363 F. Supp. 3d 511 (D. Delaware, 2019)
Exergen Corp. v. Brooklands Inc.
125 F. Supp. 3d 307 (D. Massachusetts, 2015)
Thales Visionix, Inc. v. United States
122 Fed. Cl. 245 (Federal Claims, 2015)
Internet Patents Corporation v. Active Network, Inc.
790 F.3d 1343 (Federal Circuit, 2015)
Wireless Media Innovations, LLC v. Maher Terminals, LLC
100 F. Supp. 3d 405 (D. New Jersey, 2015)
Morsa v. Facebook, Inc.
77 F. Supp. 3d 1007 (C.D. California, 2014)
SmartGene, Inc. v. Advanced Biological Laboratories, SA
555 F. App'x 950 (Federal Circuit, 2014)
Bhupinder Singh v. Eric Holder, Jr.
539 F. App'x 711 (Ninth Circuit, 2013)
Perkinelmer, Inc. v. Intema Ltd.
496 F. App'x 65 (Federal Circuit, 2012)
Smartgene, Inc. v. Advanced Biological Laboratories, Sa
852 F. Supp. 2d 42 (District of Columbia, 2012)
Classen Immunotherapies, Inc. v. Biogen Idec
659 F.3d 1057 (Federal Circuit, 2011)
CyberSource Corp. v. Retail Decisions, Inc.
654 F.3d 1366 (Federal Circuit, 2011)
BANCORP SERVICES v. Sun Life Assur. Co. of Canada
771 F. Supp. 2d 1054 (E.D. Missouri, 2011)
CyberSource Corp. v. Retail Decisions, Inc.
620 F. Supp. 2d 1068 (N.D. California, 2009)
In Re Bilski
545 F.3d 943 (Federal Circuit, 2008)
In Re Comiskey
499 F.3d 1365 (Federal Circuit, 2007)

Cite This Page — Counsel Stack

Bluebook (online)
888 F.2d 835, 12 U.S.P.Q. 2d (BNA) 1824, 1989 U.S. App. LEXIS 16528, 1989 WL 130053, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-ralph-r-grams-and-dennis-c-lezotte-cafc-1989.